Megan Schaeffer

Megan Schaeffer’s biopharma career spans almost 20 years in multiple cross-functional roles across the drug development process, maintaining a primary focus in oncology. Prior to joining Context, Megan was Vice President, Clinical Operations at Geron Corporation where she was responsible for oversight of all clinical trial activities, clinical operations strategy, planning, and execution, including registrational studies for Geron’s first commercial product, RyteloTM (imelstat). Megan spent over a decade at GSK in roles of increasing responsibility across clinical operations, ethics and compliance, and quality. Earlier in her career, Megan worked in clinical operations and quality at PPD and ICON. Megan holds a bachelor’s degree from Chestnut Hill College.